HealthEquity reported 19% revenue growth but missed Q4 EPS estimates. Analysts see earnings improving as cybersecurity costs ease and HSA growth continues.
Latest Ratings for HQY
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 2022 | Deutsche Bank | Maintains | Buy | |
| Dec 2021 | JP Morgan | Maintains | Overweight | |
| Dec 2021 | Deutsche Bank | Maintains | Buy |
